Go to Page # Page of 10

Targeting the Endothelin A Receptor to Inhibit Cyclooxygenase Expression in Ovarian Carcinoma Cells

 Francesca Spinella,1 Laura Rosano`, Valeriana Di Castro, Maria Rita Nicotra, Pier Giorgio Natali, an
Description: New therapies against cancer are based on targeting cyclooxygenase (COX)-2. Activation of the endothelin A receptor (ETAR) by endothelin (ET)-1 is biologically relevant in several malignancies, including ovarian carcinoma. In this tumor, the ET-1/ETAR autocrine pathway promotes mitogenesis, apoptosis protection, invasion, and neoangiogenesis.
Views: 1885
Domain: Medical
Category: Biotech/Pharma
4670 Vol. 10, 4670 � 4679, July 15, 2004

Clinical Cancer Research

Featured Article

Inhibition of Cyclooxygenase-1 and -2 Expression by Targeting the Endothelin A Receptor in Human Ovarian Carcinoma Cells
Francesca Spinella,1 Laura Rosano,1 ` Valeriana Di Castro,1 Maria Rita Nicotra,3 Pier Giorgio Natali,2 and Anna Bagnato1
Laboratories of 1Molecular Pathology and Ultrastructure and ... See more

Recent Presentations

Raphael Procher
18 June, 2019
Laura Collie PhD
17 June, 2019
Shuyang Zhang MD
14 June, 2019